» Articles » PMID: 31790730

Generation, Purification and Engineering of Extracellular Vesicles and Their Biomedical Applications

Overview
Journal Methods
Specialty Biochemistry
Date 2019 Dec 3
PMID 31790730
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Extracellular vesicles (EVs), derived from cell membranes, demonstrate the potential to be excellent therapeutics and drug carriers. Although EVs are promising, the process to develop high-quality and scalable EVs for their translation is demanding. Within this research, we analyzed the production of EVs, their purification and their post-bioengineering, and we also discussed the biomedical applications of EVs. We focus on the developments of methods in producing EVs including biological, physical, and chemical approaches. Furthermore, we discuss the challenges and the opportunities that arose when we translated EVs in clinic. With the advancements in nanotechnology and immunology, genetically engineering EVs is a new frontier in developing new therapeutics in order to tailor to individuals and different disease stages in treatments of cancer and inflammatory diseases.

Citing Articles

Engineering strategies for apoptotic bodies.

Hu Z, Qian S, Zhao Q, Lu B, Lu Q, Wang Y Smart Med. 2024; 3(3):e20240005.

PMID: 39420952 PMC: 11425054. DOI: 10.1002/SMMD.20240005.


Bacterial derivatives mediated drug delivery in cancer therapy: a new generation strategy.

Ijaz M, Hasan I, Chaudhry T, Huang R, Zhang L, Hu Z J Nanobiotechnology. 2024; 22(1):510.

PMID: 39182109 PMC: 11344338. DOI: 10.1186/s12951-024-02786-w.


Macrophage-Derived Exosomes as Advanced Therapeutics for Inflammation: Current Progress and Future Perspectives.

Song Y, Hu J, Ma C, Liu H, Li Z, Yang Y Int J Nanomedicine. 2024; 19:1597-1627.

PMID: 38406601 PMC: 10888065. DOI: 10.2147/IJN.S449388.


Therapeutic effects of human umbilical cord mesenchymal stem cell-derived extracellular vesicles on ovarian functions through the PI3K/Akt cascade in mice with premature ovarian failure.

Li N, Fan X, Liu L, Liu Y Eur J Histochem. 2023; 67(3).

PMID: 37503653 PMC: 10476539. DOI: 10.4081/ejh.2023.3506.


Extracellular vesicle-based biovectors in chronic wound healing: Biogenesis and delivery approaches.

Garima , Sharma D, Kumar A, Mostafavi E Mol Ther Nucleic Acids. 2023; 32:822-840.

PMID: 37273778 PMC: 10238601. DOI: 10.1016/j.omtn.2023.05.002.


References
1.
Wang Z, Tiruppathi C, Cho J, Minshall R, Malik A . Delivery of nanoparticle: complexed drugs across the vascular endothelial barrier via caveolae. IUBMB Life. 2011; 63(8):659-67. PMC: 3142311. DOI: 10.1002/iub.485. View

2.
Angsantikul P, Thamphiwatana S, Zhang Q, Spiekermann K, Zhuang J, Fang R . Coating nanoparticles with gastric epithelial cell membrane for targeted antibiotic delivery against infection. Adv Ther (Weinh). 2018; 1(2). PMC: 6176867. DOI: 10.1002/adtp.201800016. View

3.
Wang M, Altinoglu S, Takeda Y, Xu Q . Integrating Protein Engineering and Bioorthogonal Click Conjugation for Extracellular Vesicle Modulation and Intracellular Delivery. PLoS One. 2015; 10(11):e0141860. PMC: 4631329. DOI: 10.1371/journal.pone.0141860. View

4.
Potter D, Miyazawa B, Gibb S, Deng X, Togaratti P, Croze R . Mesenchymal stem cell-derived extracellular vesicles attenuate pulmonary vascular permeability and lung injury induced by hemorrhagic shock and trauma. J Trauma Acute Care Surg. 2017; 84(2):245-256. PMC: 6378956. DOI: 10.1097/TA.0000000000001744. View

5.
Wang S, Gao J, Wang Z . Outer membrane vesicles for vaccination and targeted drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2018; 11(2):e1523. PMC: 6203682. DOI: 10.1002/wnan.1523. View